Experimental Therapeutics of Neurodegenerative Disorders: Unmet Needs (Q45296771)

11 December 2017

title

Experimental therapeutics of neurodegenerative disorders: unmet needs (English)

1 reference

11 December 2017

Experimental Therapeutics of Neurodegenerative Disorders: Unmet Needs (English)

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

15 January 2025

1 reference

I. Shoulson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9804537

15 January 2025

publication date

1 November 1998

1 reference

11 December 2017

6 November 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9804537

https://www.science.org/doi/pdf/10.1126/science.282.5391.1072

15 January 2025

language of work or name

English

0 references

work available at URL

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

15 January 2025

1 reference

11 December 2017

volume

282

1 reference

11 December 2017

issue

5391

1 reference

11 December 2017

page(s)

1072-1074

1 reference

publication type of scholarly work

11 December 2017

review article

1 reference

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

cites work

1

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group

15 January 2025

2

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

15 January 2025

3

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Aromatic Amino Acids and Modification of Parkinsonism

15 January 2025

5

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Journal of Pharmacology and Experimental Therapeutics

15 January 2025

6

195

453

Lloyd K. G.

1975

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Treatment of Parkinson's disease

15 January 2025

7

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease

15 January 2025

8

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Rethinking genotype and phenotype correlations in polyglutamine expansion disorders

15 January 2025

9

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia

15 January 2025

11

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

DATATOP: A decade of neuroprotective inquiry

15 January 2025

13

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Amyloid beta amyloidosis in Alzheimerʼs disease

15 January 2025

16

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

15 January 2025

17

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

α-Synuclein in Lewy bodies

15 January 2025

18

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases?

15 January 2025

19

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

15 January 2025

20

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

15 January 2025

24

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

15 January 2025

26

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease

15 January 2025

27

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

15 January 2025

28

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

15 January 2025

30

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Mutant genes in familial Alzheimer's disease and transgenic models

15 January 2025

31

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Genetic Neurodegenerative Diseases: The Human Illness and Transgenic Models

15 January 2025

34

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila

15 January 2025

35

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Drug Delivery to the Brain

15 January 2025

36

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

Neural Transplantation: A Call for Patience Rather Than Patients

15 January 2025

38

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.282.5391.1072

15 January 2025

Identifiers

1 reference

11 December 2017

1 reference